Dld Asset Management, LP Natera, Inc. Put Options Transaction History

Dld Asset Management, LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 12, 2024	SELL	$37.55 - $62.64 $908,709 - $1.52 Million	-24,200 Reduced 23.61%	78,300 $4.9 Million
Q3 2023 Nov 13, 2023	BUY	$43.4 - $62.52 $4.45 Million - $6.41 Million	102,500 New	102,500 $4.54 Million
Q4 2022 Feb 13, 2023	SELL	$34.17 - $47.91 $3.08 Million - $4.31 Million	-90,000 Reduced 46.75%	102,500 $4.12 Million
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $92,325 - $141,700	2,500 Added 1.32%	192,500 $8.43 Million
Q2 2022 Aug 12, 2022	BUY	$28.13 - $44.54 $3.09 Million - $4.9 Million	110,000 Added 137.5%	190,000 $6.73 Million
Q1 2022 May 13, 2022	BUY	$30.32 - $91.33 $2.43 Million - $7.31 Million	80,000 New	80,000 $3.26 Million

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.